. 2012 Mar 6;32(4):663–669. doi: 10.1007/s10875-012-9656-5

Table VIII.

Pharmacokinetic parameters of specific antibodies in patients infused every 4 weeks

	Tetanus (N = 16) (IU/mL)	H. influenzae b (N = 15) (mg/L)	S. pneumoniae serotypes (μg/mL) (N = 16)
	Tetanus (N = 16) (IU/mL)	H. influenzae b (N = 15) (mg/L)	14	19A	23F
Elimination half-life (days)	83.76 (n = 14)	25.16^a (n = 14)	40.77 (n = 15)	60.04 (n = 15)	29.98 (n = 14)
Cmax (units)	6.96	6.62	14.62	46.14	36.38
Tmax (days)	0.131	0.644	1.821	1.861	1.682
AUC _0-t (units*days)	142.48 (n = 14)	96.09 (n = 14)	253.99 (n = 15)	1026.63 (n = 15)	563.89 (n = 15)

^aOutlying value of patient 6003 was excluded from calculation.